Koers Sansure Biotech Inc.
Aandelen
688289
CNE1000043J1
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,13 CNY | -1,90% | -9,47% | -2,15% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 10,95 mld. 79,13 mld. 10,14 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
45,5
x | K/w-verhouding 2025 * |
29,4
x | Werknemers | 2.567 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 45,91% |
1 dag | -1,90% | ||
1 week | -9,47% | ||
Lopende maand | -12,29% | ||
1 maand | -9,89% | ||
3 maanden | +3,91% | ||
6 maanden | +12,73% | ||
Lopend jaar | -2,15% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Wu Tan
CHM | Chairman | 40 | 01-01-10 |
Zhu Peng
DFI | Director of Finance/CFO | 48 | 01-08-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
You Lin Qiao
BRD | Director/Board Member | 68 | 08-07-19 |
Li Zhong Dai
CEO | Chief Executive Officer | 56 | 23-04-08 |
Xia Lin Yu
BRD | Director/Board Member | 45 | 01-12-08 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.04% | 1 M€ | -11,94% | - | |
0.12% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 19,13 | -1,90% | 4 326 717 |
26-03-24 | 19,5 | -3,66% | 6 600 894 |
25-03-24 | 20,24 | -2,22% | 2 469 791 |
22-03-24 | 20,7 | +0,10% | 2 776 825 |
21-03-24 | 20,68 | -2,13% | 3 354 730 |
slotkoers Shanghai S.E., 27 maart 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,15% | 1,51 mld. | |
-4,69% | 8,1 mld. | |
-4,85% | 5,13 mld. | |
+2,96% | 4,72 mld. | |
-34,08% | 4,4 mld. | |
-2,48% | 4,14 mld. | |
+15,50% | 2,82 mld. | |
+3,24% | 2,55 mld. | |
+11,81% | 1,92 mld. | |
-1,77% | 1,65 mld. |